- GlobeNewswire•3 months agoAptose Biosciences and CrystalGenomics Announce Exclusive Agreement for Non-Covalent BTK / FLT3 / AURK Inhibitor
TORONTO and SEOUL, South Korea, June 08, 2016-- Aptose Biosciences Inc. and CrystalGenomics, Inc. today announced an exclusive global option and license agreement focused on the development of CG026806, ...
We're sorry this is all we were able to find about this topic.
CrystalGenomics, Inc. (083790.KQ)
KOSDAQ - KOSDAQ Delayed Price. Currency in KRW
|Day's Range||26,900.00 - 27,500.00|
|52wk Range||26,900.00 - 27,500.00|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||N/A|
|Avg Vol (3m)||N/A|
|Dividend & Yield||N/A (N/A)|